263 related articles for article (PubMed ID: 16671090)
1. Survivin in esophageal cancer: An accurate prognostic marker for squamous cell carcinoma but not adenocarcinoma.
Rosato A; Pivetta M; Parenti A; Iaderosa GA; Zoso A; Milan G; Mandruzzato S; Del Bianco P; Ruol A; Zaninotto G; Zanovello P
Int J Cancer; 2006 Oct; 119(7):1717-22. PubMed ID: 16671090
[TBL] [Abstract][Full Text] [Related]
2. Overexpression of survivin mRNA is associated with a favorable prognosis following neoadjuvant radiochemotherapy in esophageal cancer.
Warnecke-Eberz U; Hokita S; Xi H; Higashi H; Baldus SE; Metzger R; Brabender J; Bollschweiler E; Mueller RP; Dienes HP; Hoelscher AH; Schneider PM
Oncol Rep; 2005 Jun; 13(6):1241-6. PubMed ID: 15870949
[TBL] [Abstract][Full Text] [Related]
3. Overexpression of PLK1 is associated with poor survival by inhibiting apoptosis via enhancement of survivin level in esophageal squamous cell carcinoma.
Feng YB; Lin DC; Shi ZZ; Wang XC; Shen XM; Zhang Y; Du XL; Luo ML; Xu X; Han YL; Cai Y; Zhang ZQ; Zhan QM; Wang MR
Int J Cancer; 2009 Feb; 124(3):578-88. PubMed ID: 19004025
[TBL] [Abstract][Full Text] [Related]
4. survivin messenger RNA expression is a good prognostic biomarker for oesophageal carcinoma.
Ikeguchi M; Kaibara N
Br J Cancer; 2002 Oct; 87(8):883-7. PubMed ID: 12373603
[TBL] [Abstract][Full Text] [Related]
5. High survivin expression is associated with favorable outcome in advanced primary oral squamous cell carcinoma after radiation therapy.
Freier K; Pungs S; Sticht C; Flechtenmacher C; Lichter P; Joos S; Hofele C
Int J Cancer; 2007 Feb; 120(4):942-6. PubMed ID: 17187360
[TBL] [Abstract][Full Text] [Related]
6. Up-regulation of survivin in oral squamous cell carcinoma correlates with poor prognosis and chemoresistance.
Su L; Wang Y; Xiao M; Lin Y; Yu L
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2010 Oct; 110(4):484-91. PubMed ID: 20868995
[TBL] [Abstract][Full Text] [Related]
7. Insulin-like growth factor-1 receptor as a novel prognostic marker and its implication as a cotarget in the treatment of human adenocarcinoma of the esophagus.
Kalinina T; Bockhorn M; Kaifi JT; Thieltges S; Güngör C; Effenberger KE; Strelow A; Reichelt U; Sauter G; Pantel K; Izbicki JR; Yekebas EF
Int J Cancer; 2010 Oct; 127(8):1931-40. PubMed ID: 20104520
[TBL] [Abstract][Full Text] [Related]
8. Cortactin, fascin, and survivin expression associated with clinicopathological parameters in esophageal squamous cell carcinoma.
Hsu KF; Lin CK; Yu CP; Tzao C; Lee SC; Lee YY; Tsai WC; Jin JS
Dis Esophagus; 2009; 22(5):402-8. PubMed ID: 19207554
[TBL] [Abstract][Full Text] [Related]
9. Immunohistochemical analysis of nuclear survivin expression in esophageal squamous cell carcinoma.
Mega S; Miyamoto M; Li L; Kadoya M; Takahashi R; Hase R; Kaneko H; Shichinohe T; Kawarada Y; Itoh T; Morikawa T; Kondo S
Dis Esophagus; 2006; 19(5):355-9. PubMed ID: 16984532
[TBL] [Abstract][Full Text] [Related]
10. Failure in downregulation of intratumoral survivin expression following neoadjuvant chemoradiation in esophageal cancer.
Vallböhmer D; Kuhn E; Warnecke-Eberz U; Brabender J; Hoffmann AC; Metzger R; Baldus SE; Drebber U; Hoelscher AH; Schneider PM
Pharmacogenomics; 2008 Jun; 9(6):681-90. PubMed ID: 18518847
[TBL] [Abstract][Full Text] [Related]
11. Stage and mRNA expression of survivin in lymph node as prognostic indicators in patients with oral squamous cell carcinoma.
Kim MJ; Lim KY; Kim JW; Nam IW; Lee JH; Myoung H
Cancer Lett; 2005 Jun; 224(2):253-61. PubMed ID: 15914276
[TBL] [Abstract][Full Text] [Related]
12. Survivin antiapoptotic gene expression as a prognostic factor in non-small cell lung cancer: in situ hybridization study.
Karczmarek-Borowska B; Filip A; Wojcierowski J; Smoleń A; Pilecka I; Jabłonka A
Folia Histochem Cytobiol; 2005; 43(4):237-42. PubMed ID: 16382892
[TBL] [Abstract][Full Text] [Related]
13. Survivin expression in oesophageal squamous cell carcinoma: its prognostic impact and splice variant expression.
Takeno S; Yamashita S; Takahashi Y; Ono K; Kamei M; Moroga T; Kawahara K
Eur J Cardiothorac Surg; 2010 Feb; 37(2):440-5. PubMed ID: 19699104
[TBL] [Abstract][Full Text] [Related]
14. Assessment of prognostic significance of cytoplasmic survivin expression in advanced oesophageal cancer.
Dabrowski A; Filip A; Zgodziński W; Dabrowska M; Polańska D; Wójcik M; Zinkiewicz K; Wallner G
Folia Histochem Cytobiol; 2004; 42(3):169-72. PubMed ID: 15493578
[TBL] [Abstract][Full Text] [Related]
15. [Expression of survivin and its significance in esophageal cancer].
Zhu HX; Wang YH; Zhou CQ; Zhang G; Bai JF; Quan LP; Liu ZH; Xu NZ
Zhonghua Zhong Liu Za Zhi; 2005 Jan; 27(1):22-4. PubMed ID: 15771792
[TBL] [Abstract][Full Text] [Related]
16. Expression of chemokine receptor CXCR4 in esophageal squamous cell and adenocarcinoma.
Gockel I; Schimanski CC; Heinrich C; Wehler T; Frerichs K; Drescher D; von Langsdorff C; Domeyer M; Biesterfeld S; Galle PR; Junginger T; Moehler M
BMC Cancer; 2006 Dec; 6():290. PubMed ID: 17176471
[TBL] [Abstract][Full Text] [Related]
17. Evidence of androgen receptor expression in squamous and adenocarcinoma of the esophagus.
Tihan T; Harmon JW; Wan X; Younes Z; Nass P; Duncan KL; Duncan MD
Anticancer Res; 2001; 21(4B):3107-14. PubMed ID: 11712819
[TBL] [Abstract][Full Text] [Related]
18. Down-regulation of nerve growth factor in poorly differentiated and advanced human esophageal cancer.
Zhu ZW; Friess H; Wang L; Di Mola FF; Zimmermann A; Büchler MW
Anticancer Res; 2000; 20(1A):125-32. PubMed ID: 10769644
[TBL] [Abstract][Full Text] [Related]
19. Expression of IAP family proteins in esophageal cancer.
Nemoto T; Kitagawa M; Hasegawa M; Ikeda S; Akashi T; Takizawa T; Hirokawa K; Koike M
Exp Mol Pathol; 2004 Jun; 76(3):253-9. PubMed ID: 15126108
[TBL] [Abstract][Full Text] [Related]
20. Programmed cell death 4 protein in esophageal cancer.
Fassan M; Cagol M; Pennelli G; Rizzetto C; Giacomelli L; Battaglia G; Zaninotto G; Ancona E; Ruol A; Rugge M
Oncol Rep; 2010 Jul; 24(1):135-9. PubMed ID: 20514454
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
